NexoBrid 5 g lyophilized powder (containing 4.85 grams of anacaulase-bcdb) and one glass jar of 50 g gel vehicle per carton Images
Generic Name: anacaulase
This medication has been identified as NexoBrid 5 g lyophilized powder (containing 4.85 grams of anacaulase-bcdb) and one glass jar of 50 g gel vehicle per carton. It is supplied by Vericel Corporation.
NexoBrid is used in the treatment of Thermal Burn and belongs to the drug class topical debriding agents. NexoBrid 5 g lyophilized powder (containing 4.85 grams of anacaulase-bcdb) and one glass jar of 50 g gel vehicle per carton is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
NexoBrid
- Generic Name
- anacaulase
- Strength
- 5 g lyophilized powder (containing 4.85 grams of anacaulase-bcdb) and one glass jar of 50 g gel vehicle per carton
- Availability
- Prescription only
- Drug Class
- Topical debriding agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Vericel Corporation
- National Drug Code (NDC)
- 69866-2005
More about NexoBrid (anacaulase topical)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: topical debriding agents
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
